(Q74201928)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9470808%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

title

Etoposide in malignant pleural mesothelioma: two phase II trials of the EORTC Lung Cancer Cooperative Group (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9470808%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

main subject

phase II clinical trial

1 reference

malignant pleural mesothelioma

inferred from title

1 reference

1 reference

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9470808%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Giuseppe Giaccone

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9470808%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

2

P E Postmus

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9470808%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

author name string

T Sahmoud

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9470808%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

C van Pottelsberghe

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9470808%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

K Mattson

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9470808%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

L Tammilehto

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9470808%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

T A Splinter

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9470808%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

A S Planting

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9470808%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

T Sutedja

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9470808%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

J van Pawel

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9470808%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

P Baas

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9470808%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

K J Roozendaal

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9470808%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

M Schrijver

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9470808%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

A Kirkpatrick

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9470808%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

M Van Glabbeke

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9470808%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

A Ardizzoni

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9470808%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

publication date

1 November 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9470808%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Cancer

9 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9470808%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

volume

33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9470808%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

issue

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9470808%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

page(s)

2211-2215

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9470808%20AND%20SRC:MED&resulttype=core&format=json

Trends in Mesothelioma Incidence in Norway 1960-1988

9 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900183-4

7 January 2021

Chemotherapy in malignant pleural mesothelioma. A review.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900183-4

7 January 2021

Etoposide (VP-16-213). Current status of an active anticancer drug

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900183-4

7 January 2021

The clinical pharmacology of etoposide and teniposide

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900183-4

7 January 2021

A randomized trial to evaluate the effect of schedule on the activity of etoposide in small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900183-4

7 January 2021

A randomized trial of two etoposide schedules in small-cell lung cancer: the influence of pharmacokinetics on efficacy and toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900183-4

7 January 2021

Chronic daily administration of oral etoposide in refractory lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900183-4

7 January 2021

A clinical trial of the oral form of 4′-demethyl-epipodophyllotoxin-β-D ethylidene glucoside (NSC 141540) VP 16–213

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900183-4

7 January 2021

The influence of the diagnostic technique on the histopathological diagnosis in malignant mesothelioma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900183-4

7 January 2021

Pleuropneumonectomy in the management of diffuse malignant mesothelioma of the pleura. Experience with 29 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900183-4

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900183-4

7 January 2021

The determinatio of the number of patients required in a preliminary and a follow-up trial of a new chemotherapeutic agent

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900183-4

7 January 2021

Variable bioavailability following repeated oral doses of etoposide

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900183-4

7 January 2021

A phase II study of VP-16 and cisplatin in patients with unresectable malignant mesothelioma. An NCI Canada Clinical Trials Group Study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900183-4

7 January 2021

Phase II study of a short course of weekly high-dose cisplatin combined with long-term oral etoposide in pleural mesothelioma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900183-4

7 January 2021

10.1016/S0959-8049(97)00183-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9470808%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference